22 November 2022
ssued: 22 November 2022, London UK GSK provides an update on Blenrep (belantamab mafodotin-blmf) US marketing authorisation GSK plc (LSE/NYSE: GSK) today announced it has initiated the process…
22 November 2022 Softcat plc Q1 2023 Trading Update Softcat plc (“Softcat”, or the “Company”), a leading UK provider of IT infrastructure technology and services, today publishes its trading update…
22 November 2022 Cranswick plc (“Cranswick” or “the Company” or “the Group”), a leading UK food producer, today announces its unaudited results for the…
Caledonia Investments plc (“Caledonia” or the “Company”) announces that Tim Livett, Chief Financial Officer, has advised the board of his intention to retire and…
Financial highlights 6 months Year 30 Sep 2022 31 Mar 2022 Change Net asset value per share total return* 4.5% 27.9% Net asset…
22 November 2022 Interim results for the six months to 30 September 2022 Investing in people, performance and environment for the long-term Robust financial…
22 November 2022 Assura plc Delivering continued growth Assura plc (“Assura”), the leading primary care property investor and developer, today announces its results for…
Trading Update and Delay to Audited Results RNS Number : 1346H Carr’s Group PLC 22 November 2022 CARR’S GROUP PLC (“Carr’s” or the “Group”)…